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A cryptic cycle in haematopoietic niches promotes
initiation of malaria transmission and evasion of
chemotherapy
Rebecca S. Lee1, Andrew P. Waters 1 & James M. Brewer 1
Blood stage human malaria parasites may exploit erythropoietic tissue niches and colonise
erythroid progenitors; however, the precise influence of the erythropoietic environment on
fundamental parasite biology remains unknown. Here we use quantitative approaches to
enumerate Plasmodium infected erythropoietic precursor cells using an in vivo rodent model
of Plasmodium berghei. We show that parasitised early reticulocytes (ER) in the major sites of
haematopoiesis establish a cryptic asexual cycle. Moreover, this cycle is characterised by
early preferential commitment to gametocytogenesis, which occurs in sufficient numbers to
generate almost all of the initial population of circulating, mature gametocytes. In addition,
we show that P. berghei is less sensitive to artemisinin in splenic ER than in blood, which
suggests that haematopoietic tissues may enable origins of recrudescent infection and
emerging resistance to antimalarials. Continuous propagation in these sites may also provide
a mechanism for continuous transmission and infection in malaria endemic regions.
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Transmission of malaria parasites (Plasmodium spp.) iseffected by the small proportion of intra-erythrocyticparasites that commit to sexual development, forming
either male or female gametocytes. Timely and sufficient
expression of the transcription factor AP2-G is a prerequisite for
commitment and is regulated epigenetically. Commitment at the
level of the population appears to be a blend of stochastic acti-
vation and response to the environment1,2. The environmental
conditions that blood stage Plasmodium are exposed to are varied.
For example, many species of Plasmodium have a well-
characterised proclivity to invade immature, circulating ery-
throid cells, suggesting that erythropoietic tissues could represent
logical but under-investigated sites of colonisation3,4. Indeed, all
stages of human infective Plasmodium falciparum have been
demonstrated within the bone marrow (BM) parenchyma, with
immature gametocytes having a relative enrichment within the
extravascular tissue resident erythroid cells5,6. P. falciparum
haemozoin was also detectable in BM parenchyma of an artificial
humanised mouse model, suggesting that Plasmodium, or at least
its products can access the BM parenchyma. Nonetheless, due to
the species restriction of P. falciparum this model cannot be used
to investigate the invasion of progenitor cells within the haema-
topoietic tissue7. Therefore, it remains unclear if the presence of
gametocytes in intact BM parenchyma arises from preferential
homing of cells containing gametocyte-committed parasites or if
commitment was selectively stimulated by parasite colonisation of
immature erythroid cells in vivo as has been seen in vitro8–10.
Here we investigated in vivo the parasitisation and gametocyte
formation within the erythroid precursor cells of the major sites
of murine haematopoiesis (the BM and the spleen). Using a
quantitative flow cytometry based approach11, we identify the
establishment of a cryptic asexual cycle within both tissues. The
early reticulocytes (ER) within these tissues provide a niche for
preferential gametocytogenesis, thus providing the first evidence
of de novo gametocyte formation within the in vivo haemato-
poietic environment. Moreover, parasites within splenic ER (SER)
are less sensitive to artemisinin (ART) treatment than parasites
within peripheral blood. Therefore, sites of haematopoiesis may
serve as origins of recrudescent infection and foci of emerging
resistance to antimalarial drugs. Continuous propagation in such
privileged sites may also provide a mechanism for continuing
transmission and infection in settings of seasonal malarial
infection.
Results
Plasmodium bergheiGFP infects Ter119+ CD44high erythroid
cells in vivo. To investigate the occupation of the erythropoietic
niche by Plasmodium in a quantifiable manner, we adapted and
optimised a flow cytometry based approach for distinguishing the
various stages of the erythroid lineage11. The transferrin receptor
(CD71) is routinely used to identify immature erythroid lineage
cells12–14. However, we found CD71 was an inadequate marker
for tissue resident immature cells, as it was also expressed on
erythroid cells within the circulation (Supplementary Fig. 1A) and
furthermore, was significantly downregulated on infection (p=
0.04, p= 0.005; paired t-test infected vs uninfected splenic cells in
EryB and EryC, respectively, Supplementary Fig. 1B). We there-
fore developed an analytical strategy based on CD44 expression,
which is expressed on erythroid differentiating cells, but down-
regulated during reticulocyte transmigration into the
circulation11,15 (Fig. 1a). As part of this strategy, DNA labelling
was performed on CD45low, CD11b−, Ter119+ BM cells to
resolve nucleated erythroblasts (EB) from other erythroid cells
(Fig. 1a and Supplementary Fig. 1C), where Ter119, a ubiquitous
erythroid marker, was used to resolve erythroid cells from all
other lineages. This step required optimisation to allow separation
of nucleated and non-nucleated erythroid cells when applied to
infected samples (Supplementary Fig. 1D). Subsequently, a
combination of cell size (FS-A) and CD44 expression was used to
define extravascular, tissue resident ER (DNA−CD44high) from
other erythroid populations in the DNA negative population,
and confirmed the relative proportions previously observed
(Fig. 1b)16. Cell sorting of the DNA−CD44low and ER directly
from tissue demonstrated a distinct CD44 phenotype between
reticulocytes and erythrocytes within circulation (DNA−CD44low)
and erythroid cells within tissue (DNA−CD44high), circumventing
the requirement to perform whole body perfusion (Supplementary
Fig. 1E). Within the DNA+ EB population, the change in cell size
allowed us to define three EB subpopulations, namely, immature
(largest), intermediate and mature EB (smallest), in a 1:2:4 ratio,
respectively11 (Fig. 1c). The proportions and size overlap between
the ER (red) and EB populations (black) in BM and spleen were
comparable to previously published data (Fig. 1a (composite) and
Supplementary Fig. 1F)17. Furthermore, the abundance of CD44
in any of the tissue derived erythroid cellular compartments was
unaffected by infection (Supplementary Table 1).
P. berghei preferentially invades ER in haematopoietic tissues.
The refined and adapted FACS assay was used to assess the
location and dynamics of non-circulating, haematopoietic tissue
(spleen and BM) resident infection with constitutively green
fluorescent protein (GFP) expressing P. berghei (PBGFPCON18,19)
(Fig. 1d). On day 7 postinfection (pi) both organs contained EB
and ER erythroid cells (DNA+CD44high and DNA−CD44high,
respectively) that were positive by flow cytometry for GFP
expressing parasites (Figs. 1d and 2a). In contrast to previous
non-quantitative observations of Plasmodium spp. infections
in vitro9,10, but in accordance with histological samples8, we did
not observe a significantly higher parasitaemia within the pre-
viously defined mature EB stage compared with the other larger,
more immature EB stages. Therefore, P. berghei does not appear
to have a stage-specific preference for nucleated erythroid cells of
different maturity in vivo (Fig. 2b). However, we did observe a
significant preference for ER compared to EB in both niches and
in particular (ER vs EB p= < 0.0001 and p= < 0.0001 Dunnett’s
multiple comparisons test; BM and spleen respectively), a sig-
nificant preference for SER compared with all other non-
circulating erythroid compartments (p= < 0.0001 One-way
ANOVA) (Fig. 2a). This was reflected in the relative selectivity
of P. berghei for BM EB: BM ER: spleen EB: spleen ER in the ratio
1:15:3:26, respectively (Fig. 2c). ER production results from EB
division, differentiation of the most immature EB (gate
1) amplifies ER numbers by a factor of 415,20, therefore, an
infected EB would only give rise to a single infected ER. These
data therefore suggest that the preponderance of infected ER
results from preferential invasion of ER rather than enhanced
maturation rates of EB to ER. It has been demonstrated that
Plasmodium infection causes impaired murine splenic and BM
erythropoiesis, attributed to dysregulated EB amplification21,22.
Our studies quantified this observation, identifying a significant
decrease in EB numbers within the BM on day 7 pi compared
with naive mice, with a similar trend observed in the spleen
(Fig. 2d). Despite P. berghei infection resulting in reduced num-
bers and altered stage distribution of splenic EB (Fig. 2d, e), all EB
stages remained susceptible to infection (Fig. 2f), although SER
continued to contribute the largest extravascular parasite burden
(Fig. 2g) consistent with the larger splenic erythropoietic mass.
Similar infection characteristics were observed in outbred NIH
mice indicating these effects were independent of genetic back-
ground (Supplementary Fig. 2A−H). Finally, mechanical passage
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of FACS-purified GFP+ ER and EB to naive mice resulted in
similar infection dynamics as transfer of infected blood,
demonstrating the viability of the extravascular forms (Fig. 2h).
Therefore, not only were ER and EB invaded by P. berghei but the
parasite developed in these cells in vivo suggesting that a cryptic
blood stage cycle of the parasite was established in these niches
P. berghei preferentially forms gametocytes in SER. The
observed gametocyte enrichment within BM, did not address
whether parasites were sequestered from the circulation or
developing de novo6. Interpretation may furthermore be confused
by multiply invaded cells that can occur at high parasitaemia23.
We therefore, developed tools to resolve young, actively devel-
oping gametocytes from asexual parasites for use in combination
with the protocol above to characterise the parasitised erythroid
lineage. The PBGFPCON19 parasite line was further modified to
co-express red fluorescent protein (RFP) under the control of
an early (8–12 hpi) gametocyte promoter, PBANKA_1012701,
generating PbGFPCON/RFPGAM parasites (Supplementary Fig.
3A−C). The half-life of RFP is typically 26 h in eukaryotic cells24
and therefore could identify mature gametocytes. However, we
have performed daily sampling to identify the first appearance of
RFP positive gametocytes. When comparing the tissue resident
erythroid populations, the SER was again the site of significantly
higher parasitaemia as early as day 5 pi (p= 0.0008. One-way
ANOVA)(Fig. 3a). Gametocytaemia was also greater within SER
compared with BM derived ER (day 5 pi p= <0.001, day 6 pi p=
0.036, day 7 pi p= 0.01. One-way ANOVA), which directly
translated into the highest burden of DNA−CD44high, tissue
resident gametocytes (day 5 pi p= 0.014, day 6 pi p= 0.0029, day
7 pi p= 0.0026. One-way ANOVA) (Fig. 3b, c. Supplementary
Fig 3D-G). Furthermore, this ER population had significantly
higher gametocytaemia (day 4 pi p= 0.04, day 5 pi p= <0.001,
day 6 pi p= 0.02 and day 7 pi p= 0.008, Dunnett’s multiple
comparison) that preceded appearance in peripheral blood (day 4
pi) (Fig. 3b). Taken together this suggests that non-circulating ER
provide a niche for the preferential formation of gametocytes that
subsequently enter the circulation. We also observed asexual
parasites and gametocytes within EBs from day 5 pi, as previously
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Fig. 1 Flow analysis robustly detects P. bergheiGFP-infected, Ter119+ CD44high erythroid cells. a Representative FACS gating strategy for bone marrow (BM)
and splenic resident erythroid precursors in uninfected and P. berghei-infected animals. DNA− and DNA+ erythroid cells were gated against CD44 and FS-
A to resolve CD44high early reticulocytes (ER) cells and erythroblasts (EB), respectively. The DNA−Ter119+CD44low gate was defined by the CD44
expression of erythroid cells within peripheral blood. The EB were gated in a 1:2:4 ratios to resolve immature, intermediate and mature stages, labelled 1, 2
and 3, respectively. Overlaying the DNA− and DNA+ populations (composite; top right hand side of quadrant) reveals an overlap in early reticulocyte and
erythroblast size. b To confirm erythroblast gates contained purely nucleated cells, populations were sorted from gates 1–3, stained with May-Grunwald
and examined by light microscopy. Three representative cells from each group from different sorts are shown. Scale bar: 6 μm. c Average percentage
contribution of EB, ER and Ter119+CD44low cells to the total Ter119+ cell population in the BM and spleen of BALB/c mice. d Identification of GFP
expressing P. berghei parasites (PBGFPcon) in populations of EB, ER and peripheral blood erythrocytes (P) gated according to the developed protocol
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shown for P. falciparum in vitro (Fig. 3d)6,9,10. Quantitative
analysis over time and assuming that only one daughter EB cell
inherits any intracellular parasite present, demonstrated that the
contribution of the parasitised EB population to the ensuing ER
population was consistently lower than 13% in the spleen (Table 1
and Supplementary Table 2). Thus, direct invasion of ER is
responsible for the majority of parasites observed in ER. More-
over, the RFP gametocyte proxy in this analysis confirms that the
greatest number of gametocytes within the tissue infection ori-
ginate in the ER and not the EB (Table 1). Therefore, SER is the
site of both greatest non-circulating parasitaemia resulting from
invasion and greatest gametocyte formation. Furthermore,
quantitation of parasitised, non-circulating erythroid cells that
have differentiated to produce gametocytes demonstrates that
they contribute substantially to the total number of gametocytes
in the infection (Supplementary Fig. 3H, I). Moreover, the
dynamics of extravascular gametocyte formation demonstrates
that SER are initially, virtually the sole source of circulating
gametocytes (99% on d4 of infection in NIH mice, Supplementary
Fig. 3J, K). Although, this proportion declines with time (20% on
day 7 pi), the additive contribution of SER remains substantial
suggesting that SER are a primary source of circulating gameto-
cytes (Supplementary Fig. 3J, K). Therefore, the erythropoietic
tissue in the spleen is a significant cradle for transmission.
ART does not clear P. berghei infection of SER. The influence of
a parasitised extravascular niche on effective treatment with
antimalarial drugs is also obscure. Immature circulating ery-
throcytes (reticulocytes) are significantly more complex metabo-
lically and enriched than their mature counterparts25.
Consequently, antimalarials targeting parasite metabolism might
become less effective due to the availability of metabolic resources
that can be scavenged by the parasite from the host cell thereby
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Fig. 2 P. berghei preferentially invades early reticulocytes (ER) within bone marrow (BM) and particularly spleen. a P. berghei demonstrates a preference for
infection of ER compared with erythroblasts (EB) in the BM and spleen of BALB/c mice at day 7 pi. Error bars ± SEM of individual values from the different
experiments shown as points. b P. berghei does not show a preference for particular EB stages (1–3 as defined in Fig. 1) within BM and spleen of BALB/c
mice as judged by percentage of invaded cell, under the assumption that the rate of random invasion is constant. Error bars ± SEM as in a. c The relative
selectivity index for tissue resident erythroid cells was calculated for each animal by normalising the percentage parasitemia as a fraction relative to the
smallest parasitemia. Error bars ± SEM as in a. d Numbers of total EB, though not ER are reduced in BM and spleen of infected BALB/c mice. Error bars ±
SEM as in a. e Pie charts show the average proportion of each erythroblast stage in uninfected spleen (left) and infected spleen (right) of BALB/c mice. f
P. berghei shows no preference for infection of erythroblast stages in the BM and spleen of BALB/c mice. Error bars ± SEM as in a. g P. berghei shows a
strong preference for ER vs EB compartments in spleen and BM of BALB/c mice. Infected samples n= 9; uninfected n= 9. Error bars ± SEM as in a. h 100
GFP+ ER and EB cells were FACS sorted from spleen along with 100 GFP+ erythroid cells from the peripheral blood. n= 1. These were introduced into naive
animals and the subsequent infections monitored by blood smears. Data from three independent experimental replications. Significant difference between
groups or samples was tested using a one-way ANOVA alongside Dunnett’s multiple comparisons test, except for figure e, which was measured using a
pair t-test. Significance is indicated with asterisks, denoting as follows: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001
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compensating for the drug-induced metabolic arrest25. Such
metabolic or bulk masking could be potentiated in more complex
erythropoietic precursors and possibly compounded through
reduced drug access to the extravascular niche. As such, having
established that malaria parasites form an extravascular, cryptic
cycle in haematopoietic tissues, the possible influence of this
niche on antimalarial efficacy was investigated measuring the
survival and development of parasites in different erythroid
compartments during treatment with the antimalarial, ART
(Fig. 4a). Using the standard Peters’ 4-day suppression test, low
doses (to 10 mg/kg) of ART produced increased numbers of
splenic EB/ER numbers in response to infection with P. berghei
(Fig. 4b–e and Supplementary Fig 4A−D). At 40 mg/kg the sti-
mulatory effect of ART on haematopoiesis was lost, mirroring
previous findings on the effect of ART on primary erythropoiesis
in humans26,27. Furthermore, the positive effect of ART on
haematopoiesis could occur in the absence of infection (Supple-
mentary Fig. 4E, F). In ART-treated mice, SER but not BM ER
(Supplementary Fig. 4G, H) were colonised by both sexual and
asexual P. berghei even at 40 mg/kg (Fig. 4f–h and Supplementary
Fig. 4I) and in the absence of detectable blood stage parasitaemia
(Fig. 4a). All ART-treated mice experienced recrudescence of
infection (Fig. 4i) and the data suggest therefore that SER could
be the source of recrudescence and furthermore, that expansion
of the ER cellular niche specifically in response to ART may
contribute to the failure of parasite clearance and recrudescence.
Successful mechanical passage of parenchymally located parasites
from the spleen of ART-treated animals demonstrated the con-
tinued viability of the parasites (Supplementary Fig. 4J).
Discussion
Commitment to sexual development in Plasmodium is the
result of an epigenetically regulated process that results in the
production of a specific transcription factor, termed AP2-G that
rewires transcription and initiates differentiation1,2. However,
the precise nature of the (various) triggers that result in the
epigenetic shift and the pathway(s) that effect that shift are
unclear but are coming into focus. Commitment is to a degree,
both stochastic and environmentally sensitive, for example,
positively responding to extracellular vesicles liberated from
parasite-infected erythrocytes28,29; however, other sources of
modulators and pathways of modulation of commitment may
exist, for example, the serum lipid lysophosphatidylcholine,
which acts as a negative regulator of commitment30. P. berghei
is more likely to commit to sexual development in the extra-
vascular niches of the BM and spleen than in circulating blood.
This suggests that there is commonality shared by these two
locales that exerts an influence on parasite developmental fate.
We have previously demonstrated the metabolomes of matur-
ing reticulocytes and mature erythrocytes are quite distinct and
that the former is both metabolically more complex and enri-
ched25. P. berghei preferentially invades reticulocytes and has a
consistently high rate of commitment to gametocytogenesis31
that might be influenced by the host cell metabolome. Com-
mitment to gametocytogenesis might be enhanced in extra-
vascular locales either through the direct influence of the
erythroid precursors (metabolome) or through as yet uni-
dentified features of these niches. Importantly, the proportion
of gametocytes produced in the haematopoietic tissues is sig-
nificant providing 20% of the number of bloodstream game-
tocytes on day 7 of infection. Indeed, the dynamics and extent
of extravascular gametocyte commitment is consistent with
their being the greatest source of (circulating and transmissible)
gametocytes in the early phase (day 4) of infection. The
application of cell fate marking technologies will allow an
accurate estimation of the contribution of parasites of extra-
vascular origin to transmission. These data underscore the
continuing utility of rodent models of malaria. It is not possible
to assay human haematopoietic tissue as performed here and
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Fig. 3 P. berghei gametocytes are preferentially formed within splenic early reticulocytes. Samples were taken every 24 h across an acute P. berghei
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NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-04108-9 ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:1689 | DOI: 10.1038/s41467-018-04108-9 |www.nature.com/naturecommunications 5
rodent models provide proxies that allow one to indicate what
may happen in the human setting. Although, the spleen is a less
significant site of haematopoiesis in the human compared with
the mouse, our observations in the murine spleen are generally
mirrored in the murine BM, supporting their extrapolation into
human BM infections. Furthermore, our findings are consistent
with the previously published data showing ability of P. falci-
parum to invade human ER in vitro1,2 and the presence of
haemozoin and enrichment of gametocytes in post-mortem
BM5,8.
Failure of ART mono and combination therapy has been well
documented; however, failure is preceded by a decline in para-
sitaemia to levels undetectable by standard diagnostic micro-
scopy32. In addition, clearance by artesunate requires extension of
therapy to seven consecutive days in the P. berghei model33.
Cellular environment is also significant; mutant P. berghei defi-
cient in components of the haemoglobin digestion pathway
colonise young reticulocytes in the circulation and in that
environment are partially protected from exposure to chlor-
oquine34. Clearly the enhanced survival in the face of che-
motherapeutic challenge afforded by colonisation of sites of
extravascular haematopoiesis might impact both continued
transmission recrudescence of infection in the face of drug
challenge. This work defines haematopoietic parenchyma as a
potential source of recrudescent parasites and emphasizes that
partner drugs must be effective in this locale. In addition, this
phenomenon could create an environment where drug resistant
parasites might more readily evolve due to suboptimal exposure
to administered drug. This phenomenon might be exacerbated by
the observation that ART treatment in common with the anti-
malarial pyrimethamine, can cause haemolysis35,36, albeit
through distinct pharmacological pathways37. Subsequent sti-
mulation of haematopoiesis, as observed in this study, would then
generate an enlarged, localised resource that would encourage
continued parasite survival. Furthermore, for certain classes of
drug that target intermediary metabolism or transport processes,
the evolution of drug resistance in this setting might be enhanced
further by the ready source of compensatory metabolites that the
erythroid host cell would potentially provide25,38. The rodent
infection model using the reporter lines of P. berghei and the
flow-based approach for pre-erythroid lineages employed here
would provide a means to directly test if new antimalarials have
similar effects on haematopoietic homoeostasis and lead to
reduced drug efficacy.
Extramedullary or stress haematopoiesis can occur in many
tissues, particularly in the spleen during infectious disease, as a
result of hereditary blood disorders, such as β-thalassaemia39,40,
or even following ART-induced haemolysis in dogs41. Spleno-
megaly is a significant and common feature of ongoing malaria
infection resulting from its roles as a primary filter of parasitised
erythrocytes and the seat of initial immune responses to infection,
as well as parasite-induced tissue remodelling42. In the context of
our data, such gross distortions might mask a further haemato-
poietic role for the human spleen with consequent active para-
sitism and enhanced gametocytogenesis increasing the probability
of successful transmission and furthermore, survival in a seasonal
transmission setting.
Taken together the findings reported here have significance for
the generation of transmission forms of malaria parasites and the
ability of infection to recrudesce, survive drug challenge or persist
in regions of seasonal transmission with implications for human
infections.
Methods
Mice. All animal experiments were performed within the strict parameters defined
by the Home Office and UK Animals (Scientific Procedures) Act 1986 and
approved by the University of Glasgow Ethics Committee. Six to eight week old
Female BALB/cOlaHsd(Harlan) and Hsd:NIH Swiss (Harlan), weighing 15–18 g
were obtained from Harlan Sprague Dawley Inc.
P. berghei parasite lines. The characterised P. berghei ANKA PbGFPko230p-
SMCON (507 clone1)18 was used to infect mice and as the parental line to
P. berghei ANKA PbGFPCON/RFPGAM line.
Seven-day infection. Infection of laboratory animals with P. berghei ANKA was
performed either by intra-peritoneal injection of thawed, cryopreserved stocks or
intravenously (IV) using tail blood obtained from a previously infected animal
within the experimental work flow. Vasodilation of uninfected mice was induced at
37 °C for 15–20 min. Mice were appropriately restrained and inoculated IV with
104 parasites. Parasitaemia was monitored daily either by visual inspection of
Giemsa stained thin blood smears or by flow cytometry.
Tissue collecting. Mice were killed by cervical dislocation (The Humane Killing of
Animals under Schedule 1 to the Animals Act 1986). Death was confirmed by
cardiorespiratory failure and unresponsiveness to pain stimuli. A volume of 2–5 μl
of peripheral blood was collected in 1 ml of PBS (Gibco). The spleen was removed,
weighed and placed in 1 ml of 1X PBS (Gibco) and transported on ice. The femur
was dislocated from the pelvis and the skin and muscle removed fully from the
femur and tibia before the bones were added to 1 ml PBS (Gibco) and transported
on ice. The epiphysis of the femur and tibia were removed using a single edge razor
blade (Swann Morton). The BM was perfused from the diaphysis and epiphysis
using a 5 ml syringe (BD Plastipak) and 26 G, 0.45 × 12 mm needle (14-12117,
2019-20, Henke sass wolf) containing 3 ml 4 °C 1X PBS (Gibco). The BM and the
spleen were gently dissociated into a 50 ml falcon tube (Greiner) on ice using a 40
μm cell strainer (Greiner), the plunger of a 5 ml syringe (BD Plastipak) and 4 °C
PBS (Gibco). The blood, BM and spleen cells were centrifuged at 400×g for 10 min
at 4 °C, the supernatant discarded. The BM cells were suspended in 1 ml 4 °C PBS
(Gibco) and the spleen in 10 ml. A volume of 10 μl of the single cell suspension was
suspended 1:1 in 0.04% trypan blue (Sigma). Viable cells were counted using a
haemocytometer (Nano Entek). Approximately 3 × 107 cells of each sample were
added to a 96-well plate (Costar). The plate was centrifuged at 400×g for 5 min and
the supernatant discarded.
Flow cytometry. Cell pellets were suspended in 50 μl mouse Fc block (grown in
house from 2.4G2 hybridoma) and incubated at 4 °C for 30 min. The cells were
then stained with fluorescently labelled antibodies diluted appropriately in 50 μl
mouse Fc block and Vybrant DyeCycle Ruby stain (Life Technologies) at a 1:2000
dilution (1.25 μM concentration) (Supplementary methods) before incubating in
the dark at 4 °C for 30 min. The cells were washed twice at 400×g for 3 min with 4 °
C PBS (Gibco), then stained with Fixable viability dye, eFluor 506 (ebioscience) at a
1:1000 concentration in 4 °C PBS (Gibco). The cells were incubated at 4 °C for 30
min in the dark. The cells were washed once at 400×g for 3 min with PBS (Gibco)
and suspended in FACS buffer (0.5 M EDTA in PBS). The cell suspensions were
filtered over Nitex mesh (0.2 μm mesh) into FACS tubes (Falcon). Cells were
analysed on MACSquant (Miltenyi Biotec) on the low flow rate setting. Quanti-
tative cell numbers were derived from running 10 μl of each fully stained sample on
the low flow rate setting. Data were analysed with FlowJo software (Treestar inc.).
Cell sorting. Cells were sorted on a FACS ARIA III (BD Biosciences) using a 70 μm
nozzle, into FACS tubes (Falcon) containing 1 ml 4 °C PBS (Gibco). Sulphadiazine-
enriched gametocytes (Supplementary methods) were sorted using a S3 sorter
(BioRad). The cells were injected IV into uninfected mice (Supplementary meth-
ods) or centrifuged at 400×g for 10 min and the cell pellet smeared onto a standard
microscope slide. The slides were stained in Giemsa or May-Grünwald (0.25%
Table 1 Mean percentage contribution of EB parasites to the
ER asexual parasite population 24 h later in BALB/c mice
Days
postinfection
Contribution of EB to ER
asexual parasite (%)
± SD
Contribution of EB to
ER gametocytes (%)
± SD
2 ND ND
3 ND ND
4 0.34 ± 0.6 ND
5 2.56 ± 3.89 0.8 ± 2.3
6 2.28 ± 1.24 1.6 ± 2.6
7 12.83 ± 9.88 25 ± 24
All time points n= 9; day 7 n= 8
Data from three independent experimental replications
ND not detected
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(w/v) in methanol) (Sigma-Aldrich) for 5 min, washed in 1% PBS (Gibco) being
washed in water. The slides were examined under a standard light microscope
using a ×100 objective and immersion oil.
Antibodies. PE-anti-CD44 (clone IM7) and PECY5.5-anti-CD45 (clone 30-F11)
and the isotype controls were obtained from BD Biosciences and used at a final
concentration of 1 ng/μl. Alexa Fluor 700 anti-CD11b (clone M1/70), eFluor 450
anti-CD71 (clone R17 217.1.14), APC-anti-CD71 (clone R17 217.1.4.), eFluor
450 anti-CD11b (clone M1/70), PECP CY5.5-anti-CD44 (clone IM7), eFluor 450
anti-CD45 (clone 30-F11), PECY7-anti-Ter119 (clone Ter119) and the isotype
controls were obtained from eBioscience and used at a final concentration of 1
ng/μl.
Selectivity index. The selectivity index of the BM and S EB and ER populations
was calculated for each individual animal as a fold increase in parasitaemia. The
fold increase reported for each individual was relative to the lowest percentage
parasitaemia within the four tissue resident populations.
Generation of PbGFPCON/RFPGAM. DNA constructs used in the genetic mod-
ification of P. berghei were prepared using standard molecular biology techniques
(Supplementary methods). Transfection of PbGFPcon parasites with linearized
constructs, positive and negative selection and cloning of the PbGFPCON/RFPGAM
were performed as previously described18,43,44 (Supplementary methods). Inte-
gration of the construct into the genome was checked by PCR construct (Sup-
plementary methods & Supplementary Table 3). The dynamics of the RFP signal
was investigated using a erythrocyte invasion assay was performed as described
previously45 (Supplementary methods).
Drug dosing. Peters’ 4-day suppression test was carried out on PbGFPCON/
RFPGAM infected or uninfected animals as previously described46.. Stock solutions
(10 and 100 mg/ml) of ART (Sigma-Aldrich Cat. No. 361593, t1/2= 23 min ip47)
were prepared in 100% dimethyl sulfoxide (DMSO). The ART stock solution was
then diluted in sterile water with 45% cyclodextrin (Sigma-Aldrich) so the final
concentration of cyclodextrin and DMSO were 10% and 3%, respectively. BALB/c
mice were infected IV with 106 parasites before being treated with ART (sub-
cutaneous) 1 h pi and every 24 h for three additional doses. Mice in control groups
received vehicle control (1X PBS or 3% DMSO and 10% cycle dextrin in sterile
water). Parasitaemia was monitored daily by flow cytometry. On day 4 pi para-
sitaemia was measured for all mice in the group. BM and spleen were collected
from 3 to 4 mice per group and flow cytometry analysis performed. The para-
sitaemia of the remaining mice was monitored daily.
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Fig. 4 P. berghei infection persists within splenic early reticulocytes after ART clearance of peripheral blood infection. Groups of BALB/c mice (n= 7)
received four doses of ART and were randomly sampled on day 4 pi, 24 h after the final doses (infected and uninfected vehicle controls; IVC and UVC,
respectively. 1 mg/kg n= 3, 3 mg/kg −40mg/kg n= 4). a ART doses of 20 and 40mg/kg cleared peripheral blood parasitemia of animals culled on day 4
pi. b Numbers of splenic ER in response to ART. c Numbers of splenic EB in response to ART. d The proportion of EB and ER in the spleen. e The
proportions of EB developmental stages in response to ART. f Parasitemia in splenic ER during ART treatment. g Parasite numbers in splenic ER on day 4 pi.
h Absolute splenic ER gametocyte numbers on day 4 pi. i Parasitemia of recrudescent infection observed in 20 and 40mg/kg groups (both, n= 3). One
experimental replication. Significant differences were assessed by one-way ANOVA alongside Dunnett’s multiple comparisons test and indicated with
asterisks: *p < 0.05, **p < 0.01, ***p < 0.001
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Statistics. Graphs, means, SEM and SD were calculated from three experimental
repeats in triplicate unless stated otherwise using Prism 6 (GraphPad Software).
Error bars are generated from SEM unless stated otherwise. Normality was tested. p
values were calculated using paired Student's t-test (comparisons of organs and
erythroid compartments within a group), unpaired Student's t-test (comparisons
between groups), one-way ANOVA in Prism 6 alongside Dunnett’s multiple
comparisons test (GraphPad Software). p values were calculated using for non-
normal data using Mann–Whitney U-test (GraphPad Software). Significant dif-
ference between groups or samples is indicated with asterisks, denoting as follows:
*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Data availability. The data that support the findings of this study are available
from the corresponding authors upon reasonable request.
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